Sotagliflozin Could Cut Clotting More Than Empagliflozin
Adults with type 2 diabetes and heart disease on SGLT2 drugs should note the early mouse-and-lab findings, which are not yet proven in patients.
Live Poll
Would you trust a new drug that prevents blood clots if it raised bleeding risk?